Log in

Fermenta Biotech

NSE: FERMENTA · ISIN INE225B01021 · Healthcare

₹436.35−18.65 (−4.10%)

Monday 9 November, 12:56 IST. Delayed. Source: Yahoo Finance.

Price chart

₹436.35 −18.65 (−4.10%) today

The day

Previous close
₹455.00
Open
₹459.55
Day high
₹459.55
Day low
₹433.50

Listed on NSE since 4 August 2026.

Key numbers

Market value
₹1,307.09 Cr
P/E (trailing)
21.96
EPS (trailing)
₹20.72
Price to book
3.21
Dividend yield
0.90%
Debt to equity
0.28
Profit margin
11.7%
Beta
-0.24
Volume today
41,777
Average volume
2.28 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Revenue and profit

Annual revenue and profit
YearRevenueNet profitEPS
FY23₹349.06 Cr₹-51.08 Cr₹-17.70
FY24₹333.46 Cr₹-23.06 Cr₹-7.99
FY25₹467.09 Cr₹76.86 Cr₹26.35
FY26₹523.56 Cr₹71.77 Cr₹24.51

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Quarterly results

Results for each quarter, latest first
QuarterRevenueNet profitEPSProfit vs year ago
Q2 FY27Jul–Sep 2026₹133 Cr₹10 Cr₹3.34–
Q1 FY27Apr–Jun 2026₹122 Cr₹10 Cr₹3.34–

Source: Fermenta Biotech’s results filed with NSE, consolidated (the whole group). Net profit is the share of Fermenta Biotech’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Balance sheet

What the company owns and owes, latest first
As onSeptember 2026
Fixed assets₹225 Cr
Investments₹43.65 L
Inventories₹167 Cr
Owed by customers₹124 Cr
Cash and equivalents₹30 Cr
Total assets₹696 Cr
Borrowings₹105 Cr
Total liabilities₹284 Cr
Shareholders’ equity₹418 Cr

Source: Fermenta Biotech’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

About Fermenta Biotech

Fermenta Biotech Limited, together with its subsidiaries, engages in the manufacturing and marketing of chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products in India, Europe, the United States, and internationally. It operates through Chemicals/Bulk Drug and Property segments. The company offers vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for injectables, soft gel capsules, premixes, food and beverage fortification applications; and vitamin K1, vitamin E50, phenyramidol and silicon dioxide, and fish oil cholesterol. It also provides fortified rice kernel; and Fermase PS 250 and penicillin G acylase used in manufacturing processes of various antibiotics. In addition, the company offers design, engineering, procurement, and construction of wastewater treatment plants, STPs, and ETPs, as well as operation and maintenance services. Further, it is involved in property development business; and renting and selling of properties. The company was formerly known as DIL Limited. Fermenta Biotech Limited was incorporated in 1951 and is based in Thane, India.

Industry
Drug Manufacturers - Specialty & Generic
Based in
Thane
Employees
630

Company website · Profile: Yahoo Finance

In the news

All news

No headlines name Fermenta Biotech in the last day or two.

Dividends and corporate actions

All companies
  • Dividend - Rs 3.75 Per Share

    Dividend · ex-date 5 August 2026

Source: NSE. Latest first.

Information only, not investment advice. Prices are delayed.

ShareWhatsAppTelegram

Open inZerodha ↗Groww ↗Angel One ↗For convenience only: no referral, not a recommendation.